Details of the Drug Combinations

General Information of This Drug (ID: DM704AN)

Drug Name

Sapacitabine DM704AN

Synonyms

CYC682

Indication

Disease Entry	ICD 11	Status	REF
Acute myelogenous leukaemia	2A41	Phase 3	[1]
Acute myeloid leukaemia	2A60	Phase 3	[2]
Breast cancer	2C60-2C65	Phase 2	[3]
Myelodysplastic syndrome	2A37	Phase 2	[1]
Ovarian cancer	2C73	Phase 2	[3]
Pancreatic cancer	2C10	Phase 2	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of Indication(s)

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Sapacitabine + Olaparib	DCRGLK4	Olaparib	Breast Cancer	[4]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT01303796) A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia. U.S. National Institutes of Health.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	ClinicalTrials.gov (NCT03641755) Olaparib + Sapacitabine in BRCA Mutant Breast Cancer